Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Heron Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- −14 vs. Q4 2021
- Shares held
- 108.5M
- −9.10M (−7.7%) vs. Q4 2021
- Total value
- $620.5M
- −$453.1M (−42.2%) vs. Q4 2021
- New holders
- 22
- 75 more added
- Sold out
- 36
- 47 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $57.1M |
| Q1 2026 | 167 | $125.6M |
| Q4 2025 | 170 | $203.2M |
| Q3 2025 | 172 | $192.4M |
| Q2 2025 | 171 | $272.1M |
| Q1 2025 | 165 | $274.5M |
| Q4 2024 | 161 | $175.8M |
| Q3 2024 | 173 | $242.4M |
| Q2 2024 | 190 | $453.7M |
| Q1 2024 | 161 | $330.5M |
| Q4 2023 | 151 | $191.2M |
| Q3 2023 | 141 | $121.9M |
| Q2 2023 | 149 | $114.7M |
| Q1 2023 | 162 | $163.1M |
| Q4 2022 | 176 | $289.5M |
| Q3 2022 | 186 | $514.2M |
| Q2 2022 | 174 | $321.6M |
| Q1 2022 | 186 | $620.5M |
| Q4 2021 | 200 | $1.07B |
| Q3 2021 | 197 | $1.16B |
| Q2 2021 | 189 | $1.61B |
| Q1 2021 | 193 | $1.48B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −53,993−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −38,853−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −37,662−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −28,900−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −27,904−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −27,493−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −26,755−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,818−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −18,151−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −13,319−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −11,796−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −10,527−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −4,302−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −291−100.0% | Sold out |
| Confluence Wealth Services, Inc. | 0 | $0 | 0.00% | −430−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −193−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −52−100.0% | Sold out |